AU4836790A - Pdgf-a, pdgf-aa, pdgf-ab, process for producing them and drugs containing them - Google Patents

Pdgf-a, pdgf-aa, pdgf-ab, process for producing them and drugs containing them

Info

Publication number
AU4836790A
AU4836790A AU48367/90A AU4836790A AU4836790A AU 4836790 A AU4836790 A AU 4836790A AU 48367/90 A AU48367/90 A AU 48367/90A AU 4836790 A AU4836790 A AU 4836790A AU 4836790 A AU4836790 A AU 4836790A
Authority
AU
Australia
Prior art keywords
pdgf
producing
drugs containing
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48367/90A
Inventor
Jurgen Hoppe
Herbert A. Weich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4836790A publication Critical patent/AU4836790A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU48367/90A 1989-01-12 1990-01-11 Pdgf-a, pdgf-aa, pdgf-ab, process for producing them and drugs containing them Abandoned AU4836790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3900770 1989-01-12
DE3900770A DE3900770A1 (en) 1989-01-12 1989-01-12 METHOD FOR PRODUCING PDGF-A AND PDGF-AA

Publications (1)

Publication Number Publication Date
AU4836790A true AU4836790A (en) 1990-08-13

Family

ID=6371968

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48367/90A Abandoned AU4836790A (en) 1989-01-12 1990-01-11 Pdgf-a, pdgf-aa, pdgf-ab, process for producing them and drugs containing them

Country Status (6)

Country Link
EP (1) EP0453456B1 (en)
JP (1) JPH04504407A (en)
AU (1) AU4836790A (en)
DE (2) DE3900770A1 (en)
ES (1) ES2057528T3 (en)
WO (1) WO1990008163A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651083B2 (en) * 1989-12-15 1994-07-14 Amgen, Inc. Production of biologically active platelet-derived growth factor from high expression host cell systems

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228458A1 (en) * 1992-08-27 1994-06-01 Beiersdorf Ag Multicistronic expression units and their use
DE4228457A1 (en) * 1992-08-27 1994-04-28 Beiersdorf Ag Production of heterodimeric PDGF-AB using a bicistronic vector system in mammalian cells
EP0948538B1 (en) * 1996-12-13 2008-06-11 Novartis Vaccines and Diagnostics, Inc. Analysis and separation of platelet-derived growth factor proteins
WO1999024059A1 (en) * 1997-11-07 1999-05-20 Massachusetts Institute Of Technology Pdgf-mediated microvascular communication and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801542A (en) * 1984-10-12 1989-01-31 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
EP0259632B1 (en) * 1986-08-13 1995-12-13 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
EP0682110A1 (en) * 1987-04-22 1995-11-15 Chiron Corporation Recombinant DNA encoding PDGF A-chain polypeptides
DE3725320A1 (en) * 1987-07-30 1989-02-09 Biotechnolog Forschung Gmbh EXPRESSION VECTORS AND METHOD THEREFORE FOR THE EXTRACTION OF CRO / SS GALACTOSIDASE / PTH FUSION PROTEINS AND OF PTH

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651083B2 (en) * 1989-12-15 1994-07-14 Amgen, Inc. Production of biologically active platelet-derived growth factor from high expression host cell systems

Also Published As

Publication number Publication date
DE3900770A1 (en) 1990-07-26
WO1990008163A1 (en) 1990-07-26
EP0453456A1 (en) 1991-10-30
ES2057528T3 (en) 1994-10-16
JPH04504407A (en) 1992-08-06
EP0453456B1 (en) 1993-04-28
DE59001317D1 (en) 1993-06-03

Similar Documents

Publication Publication Date Title
AU6526190A (en) 2-bicyclo-benzimidazoles, process for their production and drugs containing said compounds
AU1252088A (en) Pharmaceutical composition, pharmaceutical granulate and process for their preparation
AU7803691A (en) Means and method for forming syringe
AU2843592A (en) 3,9-diphosphaspiroundecanes and process for making 3,9-diphosphaspiroundecanes
AU1003788A (en) Heteroaryl 3-oxo-propanenitrile derivatives and process for their preparation
AU3102089A (en) Isoindolinone derivatives, processes for preparing them and medicines containing them
AU6667290A (en) Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them
HU913430D0 (en) 2-substituted-methyl-aryl-carboxylates, medical preparations containing them and process for their production
HU913656D0 (en) 9-alpha-hydroxi-11-beta-bridged steroides, method for producing them and pharmaceutical preparatives containing said compounds
AU3112089A (en) Indoloquinoline system compounds, process for their preparation, and carcinostative composition containing them
AU2845189A (en) Process for preparing 1-alkyl-5-nitroimidazoles
AU4836790A (en) Pdgf-a, pdgf-aa, pdgf-ab, process for producing them and drugs containing them
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
AU3083089A (en) Process for preparing n-sulphonyl-ureas
AU2501288A (en) Sialocylglycerolipids and method for preparing the same
AU4409689A (en) Amidofluoranited compounds, method for producing and using said compounds
AU5653390A (en) New diphosphonic acid derivatives, process for producing them and drugs containing them
AU631261B2 (en) Novel pyridine derivatives, pharmaceutical compositions containing them and process for preparing same
HRP960063B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
AU5256290A (en) Novel thiouracil derivatives, pharmaceuticalcompositions containing them and process for preparing same
AU638504B2 (en) Injectable solution and process for preparing same
AU1396288A (en) Method, apparatus for, and protein product having aligned fibers
AU1563388A (en) New macrolide derivatives, process for the preparation thereof and pharmaceutical compositions containing them
AU1694388A (en) Method for making organobis (thioether)s, and products obtained therefrom
AU4817490A (en) 2',3'-dideoxyribofuranosides and process for producing them